Bio­gen pays $900M to set­tle wide-rang­ing physi­cian kick­back claims

Look­ing to clear the deck ahead of its long-await­ed lecanemab da­ta re­lease, Bio­gen agreed to pay the US gov­ern­ment and states a whop­ping $900 mil­lion to set­tle sev­en-year-old al­le­ga­tions that it sub­mit­ted false claims to Medicare and Med­ic­aid by pay­ing kick­backs to physi­cians to in­duce them to pre­scribe Bio­gen drugs.

The set­tle­ment, which is on the high­er end of these DOJ-re­lat­ed res­o­lu­tions that have be­come com­mon in the phar­ma in­dus­try, re­solves a law­suit filed by for­mer Bio­gen em­ploy­ee (now a di­rec­tor at Gen­zyme) Michael Baw­duni­ak, who will take home al­most $250 mil­lion as part of the deal.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.